Ascend Research

CELH earnings

Analysis, not advice
This print
6 Aug 2026Q3 FY26graded 6 Aug 2026
cons 0.41 EPS / 0.87B rev
What the desk tested

Explicit conditions that would change the desk’s view, graded against the transcript below.

Bull condition triggered: Organic CELSIUS-brand North America posts ≥+10% YoY for a second consecutive quarter (Q2 would be Q2 of a restart after Q1's +6%), Alani Nu contribution is disclosed at ≥$100…
Bull condition triggered: Management explicitly quantifies ≥$50M of Alani Nu synergy realized through Q2 (even partial disclosure toward the $150M FY27 target) AND raises FY26 revenue guidance above $…
+1 more criteria on the desksign up free
From the desk's pre-read · 6 Aug 2026

CELH is scheduled to print Q2 2026 earnings on 2026-08-06, with consensus at $0.42 EPS · $0.87B revenue (FMP).

+1 more — the full pre-read is on the desksign up free
The desk's graded verdict
wobblinggraded 6 Aug 2026
FAILRevenue vs $0.87B consensus

“revenue totaled approximately $817.9 million... representing growth of 10.6%”

FAILOrganic CELSIUS-brand NA growth

“CELSIUS brand revenue decreased by approximately 11.7% in the second quarter of 2026 compared to the same period last year”

+2 more resolved criteria + the full narrative on the desksign up free

This page shows one print. The desk has published work on 4 earlier prints of CELH.

Educational analysis, not a personalised recommendation. See all covered names on the earnings calendar · part of our public track record.